|
|
|
41
|
2791D
|
OVESTIN 1MG VAG CR (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15G
|
A
|
42
|
41.9981
|
TUBE
|
1
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
Vaginal
|
6
|
ESTROGENS
|
|
|
|
|
42
|
2791D
|
OVESTIN 1MG VAG CR (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15G
|
A
|
45.80
|
45.80
|
TUBE
|
1
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
6
|
ESTROGENS
|
|
|
|
|
41
|
27921
|
OVESTIN 0.5MG OV (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15'S
|
A
|
41.9981
|
41.9981
|
PACK
|
1
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
6
|
ESTROGENS
|
|
|
|
|
42
|
27921
|
OVESTIN 0.5MG OV (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15'S
|
A
|
45.80
|
3.05
|
OV
|
15
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2026-04-01
|
2028-03-31
|
|
VAGINAL
|
6
|
ESTROGENS
|
|
|
|
|
40
|
2831AG
|
AMARYL 2MG TAB (SFA/COL) GLIMEPIRIDE
|
GLIMEPIRIDE
|
AMARYL
|
15'S
|
C
|
2.72
|
0.18
|
TABLET
|
0
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2831AG
|
AMARYL 2MG TAB (SFA) GLIMEPIRIDE (C)
|
GLIMEPIRIDE
|
AMARYL
|
15'S
|
C
|
4.08
|
0.2718
|
TAB
|
45
|
BOX
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
40
|
2831FJ
|
DAONIL 5MG TAB (SFA/COL) GLIBENCLAMIDE
|
GLIBENCLAMIDE
|
DAONIL
|
100'S
|
A
|
10.87
|
0.11
|
TABLET
|
120
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
2831GP
|
GLIMEPIRIDE 2MG TAB (DRL/AHI)
|
GLIMEPIRIDE
|
GLIMEPIRIDE
|
100'S
|
C
|
12.75
|
0.13
|
TABLET
|
0
|
TAB
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2831GT
|
GLITISOL 5MG TAB (REM) GLIBENCLAMIDE
|
GLIBENCLAMIDE
|
GLITISOL
|
40'S
|
A
|
2.15
|
0.0537
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
42
|
2831GV
|
GETRYL 2MG TAB (GET) GLIMEPIRIDE
|
GLIMEPIRIDE
|
GETRYL
|
20'S
|
C
|
1.09
|
0.05
|
TAB
|
45
|
BLIS
|
GET
|
GETZ PHARMA (PVT) LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682020
|
SULPHONYLUREAS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
42
|
2831HD
|
GLIFORD 5MG TAB (JLP) GLIBENCLAMIDE
|
GLIBENCLAMIDE
|
GLIFORD
|
200'S
|
A
|
10.33
|
0.05
|
TAB
|
120
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682020
|
SULPHONYLUREAS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
40
|
28321
|
DIAMICRON MR 60MG TAB (SER/STO) GLICLAZIDE
|
GLICLAZIDE
|
DIAMICRON MR
|
30'S
|
A
|
7.18
|
0.24
|
TABLET
|
60
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
contract extended
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-05-27
|
|
|
|
40
|
2832AT
|
DIAMICROM MR 60MG TAB (SER/COL) GLICLAZIDE
|
GLICLAZIDE
|
DIAMICROM MR
|
30'S
|
A
|
7.18
|
0.24
|
TABLET
|
60
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
Contract Extended
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-03-21
|
|
|
|
40
|
2832BA
|
AMARYL 4MG TAB (SFA/COL) GLIMEPIRIDE
|
GLIMEPIRIDE
|
AMARYL
|
15'S
|
C
|
4.08
|
0.27
|
TABLET
|
0
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2832BA
|
AMARYL 4MG TAB (SFA) GLIMEPIRIDE (C)
|
GLIMEPIRIDE
|
AMARYL
|
15'S
|
C
|
4.08
|
0.2718
|
TAB
|
60
|
BOX
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
40
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER/COL)
|
GLICLAZIDE
|
GLICLAZIDE MR
|
30'S
|
A
|
14.35
|
0.24
|
TABLET
|
60
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
Name Change
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-05-27
|
|
|
|
40
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER/COL)
|
GLICLAZIDE
|
GLICLAZIDE MR
|
30'S
|
A
|
7.18
|
0.24
|
TABLET
|
60
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2022-04-01
|
2024-03-31
|
Name Change
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-09-21
|
|
|
|
41
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER)
|
GLICLAZIDE
|
GLICLAZIDE MR
|
30'S
|
A
|
7.39
|
0.2465
|
TAB
|
60
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
42
|
2832BP
|
GLICLAZIDE MR 60MG TAB (SER)
|
GLICLAZIDE
|
GLICLAZIDE MR
|
30'S
|
A
|
7.39
|
0.25
|
TAB
|
60
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
AVENTA BARBADOS
|
B
|
682020
|
SULPHONYLUREAS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|
|
|
|
41
|
2832BQ
|
GLICLAZIDE MR 60MG TAB (SER)
|
GLICLAZIDE
|
GLICLAZIDE MR
|
30'S
|
A
|
7.39
|
0.2465
|
TAB
|
60
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
B
|
682020
|
SULPHONYLUREAS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONYLUREAS
|
|